Research Project
Grant-in-Aid for Research Activity Start-up
The enormous burden of metabolic disease in our society requires that we seek novel therapeutic strategies. Chronic inflammation inmetabolic syndrome leads to reduced systemic insulin sensitivity. In this study, we found that IRF4 is a negative regulator of inflammation in metabolic syndrome. IRF4 might be a novel therapeutic target for insulin resistance.
All 2012 2011 Other
All Journal Article (4 results) (of which Peer Reviewed: 4 results) Presentation (9 results) (of which Invited: 1 results)
Journal Clin Invest
Volume: 122 Pages: 1010-21
J Pathol
Volume: 226 Pages: 784-95
J Clin Endocrinol Metab
Volume: 97(7) Pages: 1202-7
120005232486
Endocrinology
Volume: 153(2) Pages: 612-20